Home | EndoTODAY | EndoATLAS | Blog


[¿¬¼¼´ëÇб³ °­³²¼¼ºê¶õ½º ¾Ïº´¿ø ½ÉÆ÷Áö¾ö - ÀüÀÌ¾Ï ±Øº¹]

2014 ¿¬¼¼´ëÇб³ °­³²¼¼ºê¶õ½º ¾Ïº´¿ø ½ÉÆ÷Áö¾ö - ÀüÀÌ¾Ï ±Øº¹ (How to overcome metastases, Challenge to the future for our patients)¿¡ ´Ù³à¿Ô½À´Ï´Ù. Single topicÀ» ´Ù°¢µµ·Î »ìÆ캼 ¼ö ÀÖ´Â ÁÁÀº ½Ã°£À̾ú½À´Ï´Ù. ÇÑ °¡Áö ÈìÀº ¿¬ÀÚµéÀÌ ½Ã°£À» ÁöÅ°Áö ¾ÊÀº °Í.


1. ÀüÀ̼º °£¾ÏÀÇ ÁßÀçÀû ¹æ»ç¼±ÇÐ (¿¬¼¼´ëÇб³ À̱¤ÈÆ)

1971. 12. 23. ¹Ì±¹ ´Ð½¼ ´ëÅë·ÉÀÌ ¾Ï°úÀÇ ÀüÀïÀ» ¼±Æ÷ÇÏ¿´À¸³ª ÅõÀÔµÈ ÀçÁ¤¿¡ ºñÇÏ¿© È¿°ú°¡ ¹ÌºñÇÏ¿© ±âº» °³³äÀÌ seek and destroy Àü·«¿¡¼­ target and control·Î ÀüȯµÊ.

RFA - 5°³ ¹Ì¸¸, 3 cm ¹Ì¸¸. È¿°ú´Â surgical resection°ú µ¿ÀÏÇÔ. RFA ÈÄ Ãʱ⿡´Â ¼ö¼úº¸´Ù local recur°¡ ¸¹Áö¸¸ overall survivalÀº ¼ö¼ú°ú ºñ½ÁÇÕ´Ï´Ù. ¹Ýº¹Ä¡·á°¡ °¡´ÉÇÏ°í °£±â´ÉÀÌ Àß º¸Á¸µÇ±â ¶§¹®ÀÏ °ÍÀ¸·Î »ý°¢µË´Ï´Ù.

Radioembolozation - 50 micrometer Å©±âÀÇ radioisotope-tagged microsphere (yttrium-90 tagging)°¡ ±¹¼ÒÀûÀ¸·Î ¿ªÇÒ. 2.5-11mm±îÁö È¿°ú°¡ ¹ÌĨ´Ï´Ù.

À̱¤ÈÆ ¼±»ý´ÔÀº Pancreas neuroendocrine tumor with multiple hepatic metastasis ȯÀÚ¸¦ °£¿¡ ´ëÇÑ radioembolizationÇÏ¿´°í 8°³¿ù ÈÄ °£ÀüÀÌ°¡ CR »óÅ°¡ µÇ¾î PPPD ¼ö¼úÀ» ÇÑ È¯ÀÚ¸¦ º¸¿©ÁÖ¾ú½À´Ï´Ù. ¿ø·¡ neuroendocrine tumorÀÇ °£ÀüÀÌ´Â Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀÀÌ ÁÁ´Ù°í ÇÕ´Ï´Ù.


2. ÀüÀ̾ÏÀÇ Á¤À§ÀýÁ¦ ¹æ»ç¼±Ä¡·á (Stereotatic ablative radiotherapy SABR, ¼¼À̹ö¶ó°í ÀÐÀ½) (¿¬¼¼´ëÇб³ ±èÁØ¿ø)

Çѹø ȤÀº ¼Ò¼ö·Î Ä¡·áÇÏ´Â °ÍÀÌ È¿°ú°¡ ÁÁ´Ù. HypofractionÀ̶ó°í ÇÔ. Çѹø¿¡ Ä¡·áÇÏ´Â °ÍÀ» radiosurgery¶ó°í ºÎ¸¥´Ù.

Immobilization, motion management°¡ Áß¿äÇÕ´Ï´Ù. 4D CT¸¦ ÀÌ¿ëÇÑ tracing ¹æ¹ýÀÌ ¼Ò°³µÇ¾ú½À´Ï´Ù.

Single metastasis »Ó¸¸ ¾Æ´Ï¶ó oligometastases¿¡ ´ëÇÑ Àû±ØÀûÀÎ Ä¡·áÇÏ°í ÀÖ´Ù°í ÇÕ´Ï´Ù. Oligometastases setting¿¡¼­ SABRÀº ¼ö¼ú°ú ´ëµîÇÑ ¼ºÀûÀÌ ³ª¿À°í ÀÖ½À´Ï´Ù. Survival gain»Ó¸¸ ¾Æ´Ï¶ó selection¿¡ µû¶ó survival gain±îÁö º¸ÀÌ´Â °æ¿ì°¡ ÀÖ¾ú½À´Ï´Ù.

Spine metastasis ¿¡¼­ SABRº¸´Ù ¼ö¼úÀ» ¸ÕÀú °í·ÁÇØ¾ß ÇÏ´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù.
1) Mechanical instability
2) Acute or progressive neurologic decline
3) Primary site unknown¿¡¼­ Á¶Á÷ÇÐÀû È®ÁøÀÌ ÇÊ¿äÇÔ


3. ÆóÀüÀ̾ÏÀÇ ÃÖ¼Òħ½ÀÀûÄ¡·á (¿¬¼¼´ëÇб³ À̼º¼ö)

À̼º¼ö ¼±»ýÀº "´ëÇüº´¿øº¸´Ù ¿ÀÈ÷·Á ÁßÇüº´¿ø¿¡¼­ ÀüÀ̸¦ °¡Áø ¾ÏȯÀÚ¿¡ ´ëÇÑ ¼¶¼¼ÇÑ Ä¡·á¸¦ ÇÒ ¼ö ÀÖ´Â ÀåÁ¡ÀÌ ÀÖ´Ù"°í ÇÏ¿´½À´Ï´Ù. Á¦ »ý°¢Àº "±Û½ê¿ä?" ÀÔ´Ï´Ù. Àú´Â ´ëÇü, ÁßÇüÀ¸·Î ³ª´­ ¼º°ÝÀº ¾Æ´Ï¶ó°í »ý°¢ÇÕ´Ï´Ù. ÆÀº°·Î ´Ù¸£°í Àǻ纰·Î ´Ù¸¥ °Í ¾Æ´Ò±î¿ä? Áö³ªÄ£ ´Ü¼øÈ­ÀÇ ³ª»Û ¿¹ °°½À´Ï´Ù.

°¢Á¾ ¾Ï ȯÀÚ¿¡¼­ lung noduleÀÌ ÀÖÀ» ¶§ ÀüÀÌÀÎÁö Æó¾ÏÀÎÁö ±¸ºÐÇØ¾ß ÇÕ´Ï´Ù. Melanoma³ª sarcoma¿¡¼­´Â metastasisÀÏ È®·üÀÌ ³ô½À´Ï´Ù.

ºÐ·ùMetastasisPrimary lung cancer
Sarcoma101
Melanoma101
Genitourinary cancer11
Colorectal cancer11
Head and neck cancer0.51

Criteria for metastatectomy
1) Primary tumor that has been definitely controlled.
2) Metastases limited to the lung that can be completely resected
3) Ability of the patient to tolerate the planned operation
4) Lack of a better alternative treatment

ÆóÀüÀÌ°¡ Àִ ȯÀÚ¿¡¼­ ¸²ÇÁÀý ÀüÀÌ°¡ Àִ ȯÀÚ´Â 22% Á¤µµÀε¥ ÀÌ °æ¿ì ¿¹ÈÄ°¡ ÈξÀ ¾È ÁÁ½À´Ï´Ù.


4. ôÃßÀüÀ̾ÏÀÇ ¼ö¼úÀûÄ¡·á (¿¬¼¼´ëÇб³ ¼®°æ¼ö)

Primary spine tumor¿¡ ºñÇØ metastatic spine tumor°¡ 90¹è ¸¹½À´Ï´Ù.

Total spondylectomy (ôÃß»À 1¸¶µð¸¦ ¿ÏÀüÈ÷ Á¦°ÅÇÏ´Â °Í)

Tokuhashi score·Î ¼ö¼ú ´ë»óÀ» ¼±Á¤ÇÕ´Ï´Ù.

ôÃß ¼ö¼ú °úÁ¤¿¡¼­ total spondylectomy ÈÄ "Áõ·ù¼ö + Ç×¾ÏÁ¦"·Î irrigationÀ» Çϸé contaminated tumor cellÀ» lysis½ÃÅ°±â ¶§¹®¿¡ Ãß°¡ radiation treatment´Â ÇÊ¿ä¾ø½À´Ï´Ù.